Publication:
Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI

Simple item page
dc.contributor.authorERCAN, ÇİLEM
dc.contributor.authorYAMAÇ, AYLİN HATİCE
dc.contributor.institutionauthorYAMAÇ, AYLİN HATİCE
dc.contributor.institutionauthorERCAN, ÇİLEM
dc.contributor.institutionauthorBACAKSIZ, AHMET
dc.date.accessioned2019-10-05T13:44:03Z
dc.date.available2019-10-05T13:44:03Z
dc.date.issued2015-04-01
dc.description.abstractIncreased serum levels of the activated aspartic lysosomal endopeptidase cathepsin D (CatD) have been found in patients with acute myocardial infarction (AMI). However, to date there have been no analyses of clinical follow-up data measuring the enzyme course and its role in the development of post-MI heart failure. This study aimed to evaluate the role of serum CatD activity in the development of heart failure in patients with ST-segment elevation acute myocardial infarction (STEMI).
dc.identifier
dc.identifier.citationYAMAÇ A. H. , ERCAN Ç., -Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI-, HERZ, no.6, ss.912-920, 2015
dc.identifier.pubmed25911051
dc.identifier.urihttps://hdl.handle.net/20.500.12645/2847
dc.language.isoen
dc.titleRole of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameMeme Hastalıkları Dergisi,
local.avesis.id453b4909-7a19-451b-b76b-0623605e2e51
local.avesis.response2717
local.indexed.atPubMed
local.org.facultyTıp Fakültesi
relation.isAuthorOfPublication9170fc79-989a-4ba8-b610-a6b256302c5a
relation.isAuthorOfPublication4b62f88a-cbba-4426-b872-f37090254c3b
relation.isAuthorOfPublicationaf75b431-3b28-42b6-93a9-357a5d965904
relation.isAuthorOfPublication.latestForDiscovery9170fc79-989a-4ba8-b610-a6b256302c5a

Files

Collections

Yayınlar - Eserler
Tıp Fakültesi